Acute Aortic Syndrome Clinical Trial
— ONSAAOfficial title:
French National Observatory of Aortic Syndromes
NCT number | NCT01259843 |
Other study ID # | 07387 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 2008 |
Est. completion date | December 2010 |
Verified date | August 2019 |
Source | French Cardiology Society |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study examined the clinical characteristics and conditions of care for patients with acute aortic syndrome (AAS) that will identify patients at risk for increased morbidity and mortality and provide a basis for the eventual achievement of specific studies on the optimal therapeutic management according to different risk profiles. The aim of the Observatory is to provide a photograph "size" of practices in France at present, both in the larger centers than in smaller and optimize diagnostic and therapeutic currently available by the activation pathways of rational management.
Status | Completed |
Enrollment | 280 |
Est. completion date | December 2010 |
Est. primary completion date | December 2010 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Male or female age (e) over 18 years old - Patients with a AAS duly authenticated by further tests - Patients who consented to participate in the study Exclusion Criteria: - Refusal of consent for study participation and ancillary studies - AAS occurring in the aftermath of a traumatic thoracic - Diagnosis AAS aside in favor of an alternative diagnosis |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
French Cardiology Society |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Etiology of AAS | Measure the respective contribution of each of the etiologies of AAS (aortic dissection type A aortic dissection type B aortic wall hematoma, penetrating atherosclerotic ulcer, aneurysm of the thoracic aorta complicated). | 1 day | |
Secondary | Clinical picture | Identify and define the specific clinical picture of each of these new entities recently dismembered as part of AAS. Indeed, if the clinical presentation of classic aortic dissection A and B is well known, that of other entities, individualized recently, remains poorly described. | 1 day | |
Secondary | Diagnostic tests | Evaluate the performance and the respective roles of the various diagnostic tests including recent acquisitions little or no invasive; Trans thoracic ultrasound, ultrasound and trans esophageal chest scan. | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03647566 -
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
|
||
Recruiting |
NCT05965453 -
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
|
||
Recruiting |
NCT05339529 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V
|
N/A | |
Recruiting |
NCT06277895 -
VOCs in Patients With Acute Cardiogenic Chest Pain
|
N/A | |
Completed |
NCT02273245 -
Is a Pre-contrast Scan Necesary to Diagnose Acute Aortic Syndrome?
|
N/A | |
Recruiting |
NCT04699279 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Rosuvastatin) I
|
N/A | |
Completed |
NCT04711889 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II
|
N/A | |
Enrolling by invitation |
NCT04398992 -
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
|
||
Completed |
NCT04751058 -
Genetic Profile in Patients With Aortic Syndrome
|
||
Completed |
NCT04430400 -
Integrated Diagnostic Algorithm for Acute Aortic Syndromes
|